Troikaa Pharmaceuticals Ltd.: Company Overview and Core Operations
Troikaa Pharmaceuticals Ltd. is a leading Indian multinational pharmaceutical company, established in 1983, with its headquarters located in Ahmedabad, Gujarat, India. The company operates as a vertically integrated pharmaceutical entity, engaging in Research and Development (R&D), manufacturing, marketing, sales, and export of a diverse portfolio of pharmaceutical formulations. Troikaa has established a significant global footprint, with its products being marketed in over 90 to 120 countries worldwide.
The core strength and strategic focus of Troikaa lies in the development and commercialization of Novel Drug Delivery Systems (NDDS). The company has successfully created a niche for itself in the pharmaceutical industry by leveraging its expertise in patented and innovative drug delivery technologies. This focus on NDDS is evident in its product pipeline, which includes difficult-to-manufacture products and proprietary technologies that aim to enhance efficacy, improve patient compliance, and reduce side effects compared to conventional drug delivery methods.
Principal Business Activities and Offerings
The majority of Troikaa's turnover is derived from Manufacturing. The company operates multiple state-of-the-art manufacturing facilities in Gujarat and Uttarakhand, which are compliant with stringent international regulatory standards. These facilities have received accreditations from various global regulatory bodies, including EU-GMP, PIC/S, ANVISA, and INVIMA, enabling its extensive export operations.
I. Products and Therapeutic Areas
Troikaa maintains a wide-ranging product basket spanning several key therapeutic segments, primarily defined by its NDDS innovation. The company has a portfolio of over 50 brands focusing on specialized areas.
Key Therapeutic Segments:
Pain Management: A major focus area, with products often featuring innovative delivery mechanisms to reduce pain and inflammation. A notable patented product is Dynapar QPS (Quick Penetrable System), which is an innovative metered-dose spray of diclofenac, a non-steroidal anti-inflammatory drug (NSAID).
Critical Care and Anesthesiology: The company produces a strong portfolio of products essential for critical care settings. This includes difficult-to-manufacture items such as Parenteral Emulsions, like Propofol injection and Etomidate injection, and Inhalation Agents for Anesthesia, such as Isoflurane and Sevoflurane.
Cardiology and Gynaecology: Troikaa also maintains a significant presence and product offerings within the Cardiology and Gynaecology segments.
Key Product Types and Formulations:
Finished Dosage Forms, including Injectables.
Specialized delivery forms such as Sublingual Tablets and patented packaging designs like the metered-dose spray bottle for its pain management product.
Active Pharmaceutical Ingredients (APIs): Through its subsidiary, Troikaa Pharmachem Pvt. Ltd., the company has forayed into API manufacturing, providing both Generic APIs and Innovative APIs. Examples include Sevoflurane API, Propofol API, and Desflurane API.
Contrast Media products are also part of the company's offerings.
II. Services and Business-to-Business (B2B) Offerings
Beyond its branded formulation business, Troikaa Pharmaceuticals Ltd. offers comprehensive B2B services, leveraging its advanced R&D and manufacturing capabilities. These services are crucial for its global business model and partnership development.
Contract Development and Manufacturing Organisations (CDMO) / Contract Manufacturing Organisations (CMO): The company actively offers contract manufacturing services for dosage form drugs and is open to private labeling arrangements, particularly for the EU and other international markets.
Contract Research & Product Development: Through its specialized division, Troikaa Nutrasciences (a division of Troikaa Pharmaceuticals Limited), the company provides contract research and product development services, from initial conception to the finished product, specifically in the nutraceutical space.
Nutraceuticals and Health Supplements: Troikaa Nutrasciences offers a wide range of proprietary nutraceuticals and health supplements, differentiated by technology and quality, ready for marketing. The division also highlights its revolutionary LiquiCap encapsulation technology for filling oily/liquid formulations into sealed hard gelatin capsules.
In summary, Troikaa Pharmaceuticals Ltd. is a research-driven, innovation-focused company with a multinational presence, distinguished by its leadership in Novel Drug Delivery Systems, particularly in critical care and pain management products, and supported by a robust manufacturing and B2B service platform.
Please note: This information is generated by AI. For legal use, verify with company sources.
